US Human Milk Oligosaccharides Market Size was estimated at 114.75 (USD Million) in 2023. The US Human Milk Oligosaccharides Market Industry is expected to grow from 130.5(USD Million) in 2024 to 562.5 (USD Million) by 2035. The US Human Milk Oligosaccharides Market CAGR (growth rate) is expected to be around 14.204% during the forecast period (2025 - 2035).
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Human Milk Oligosaccharides (HMOs) market is experiencing notable growth driven by an increasing awareness of the benefits of HMOs for infant health. Parents and caregivers are becoming more informed about the nutritional advantages HMOs provide, particularly in supporting gut health and enhancing immune responses in infants. This shift is supported by government initiatives promoting breastfeeding and maternal health, which emphasize the importance of natural ingredients in infant nutrition. As research continues to uncover the positive impacts of HMOs on overall health, consumers are showing a preference for products enriched with these components, creating a fertile ground for market expansion.There are significant opportunities to be captured in the development of innovative HMO formulations tailored for various age groups and specific health needs. Products that incorporate HMOs into functional foods and dietary supplements present a unique avenue for brands looking to diversify their offerings. Additionally, the growing trend towards clean label products resonates with consumers who desire transparency in ingredient sourcing and formulation. Manufacturers who can provide evidence-based formulations while maintaining high ethical standards can differentiate themselves in this burgeoning market. In recent times, the US market has seen increased investment in research and development focused on HMOs, creating momentum for future growth.Collaborations between food scientists, nutritionists, and health professionals are becoming more prevalent as companies seek to enhance the scientific backing for their products. Overall, the integration of HMOs into infant formulas and other related products is becoming a key trend, with a clear alignment with consumer preferences for health-centric and scientifically validated nutrition solutions.
US Human Milk Oligosaccharides Market Drivers
Increasing Awareness of Health Benefits
The rising awareness among consumers about the health benefits associated with Human Milk Oligosaccharides (HMOs) is driving growth in the US Human Milk Oligosaccharides Market Industry. HMOs play a crucial role in promoting gut health, enhancing immunity, and supporting brain development in infants. The Centers for Disease Control and Prevention (CDC) reported that breastfeeding rates have increased in the US, with approximately 83% of infants being breastfed at some point, as per 2020 statistics.This enhancement in breastfeeding habits is expected to create a subsequent increase in demand for HMOs, with parents seeking fortified products that offer similar benefits to those found in breast milk. Furthermore, healthcare professionals are increasingly recommending HMOs in infant formulas, which is projected to boost the market further, considering that nearly 1 in 5 infants are formula-fed exclusively at six months of age. These trends solidify the link between consumer awareness and market growth.
Growing Demand for Infant Formulas Incorporating HMOs
The increasing demand for infant formulas that incorporate Human Milk Oligosaccharides is significantly influencing the US Human Milk Oligosaccharides Market Industry. According to the American Academy of Pediatrics, approximately 70% of babies in the US consume infant formula by the age of three months. As parents seek to improve the nutritional profile of infant formulas, several prominent companies have launched products enriched with HMOs, which directly contribute to a healthier gut microbiome.For instance, leading infant formula manufacturers like Nestlé and Mead Johnson are integrating HMOs into their products, which promises potential benefits for infant health and development. The market is expected to witness a surge as more parents opt for formulas that replicate the benefits of breastfeeding.
Advancements in Research and Development
Ongoing advancements in Research and Development (R&D) related to Human Milk Oligosaccharides are acting as a key driver for the US Human Milk Oligosaccharides Market Industry. Significant investments from biotechnology firms have led to the discovery of various HMO types and their potential benefits. In 2022, the National Institutes of Health (NIH) noted a substantial increase in funding for studies focusing on HMOs, indicating a strong commitment to understanding their impact on health.Additionally, patents related to HMOs have increased by 25% over the last five years, demonstrating the growing interest in innovative applications. These advancements not only foster market growth but also enhance consumer confidence in products containing HMOs, as scientific backing continues to emerge.
US Human Milk Oligosaccharides Market Segment Insights
Human Milk Oligosaccharides Market Application Insights
The Application segment of the US Human Milk Oligosaccharides Market encompasses various critical areas that cater to the increasing demand for health-focused products. This segment is experiencing significant growth, driven by an escalating awareness among consumers regarding the health benefits associated with Human Milk Oligosaccharides (HMOs). The Infant Formula category remains a key focus area, leveraging the beneficial properties of HMOs to mimic the composition of natural human breast milk, thereby enhancing infant growth and immunological development. This focus on Infant Formula is vital as it addresses the nutritional gaps for infants who may not have access to breastfeeding, ensuring that they receive essential prebiotic benefits that support gut health and overall development.In the realm of Functional Foods, the use of HMOs is becoming increasingly recognized for enhancing the health profile of various food products. Consumers are actively seeking functional foods that contribute positively to their well-being, making this a dynamic area within the market. The integration of HMOs into Functional Foods not only provides digestive health benefits but also promotes immune system support, which aligns with the growing trend toward preventive healthcare. This evolving trend is particularly relevant in the US, where health-conscious consumers are prioritizing food choices that offer added health benefits.Moreover, the Dietary Supplements category is gaining traction as more individuals look to supplements as a means of fortifying their diets with essential nutrients, including HMOs. This category is significant as it appeals to a broad audience, including parents looking to ensure their children's health and the elderly seeking gut health support. The rising inclination toward self-care and wellness is fueling the demand for dietary products enriched with HMOs, reinforcing their role in a balanced diet.Overall, the Application segment for HMOs in the US reflects a robust landscape characterized by increasing consumer awareness and the pursuit of healthier lifestyles. Each area within this segment plays an essential role, addressing specific nutritional needs and responding to the evolving preferences of health-conscious consumers. The continuous innovation in product offerings across Infant Formula, Functional Foods, and Dietary Supplements is setting the stage for sustained market growth in the coming years. The interplay between these categories and the overarching trend toward health and wellness signifies the importance of the Application segment in shaping the future of the US Human Milk Oligosaccharides Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Human Milk Oligosaccharides Market Source Insights
The Source segment of the US Human Milk Oligosaccharides Market plays a crucial role in defining the market landscape, comprising various origins such as Human Milk, Synthetic Production, and Animal Milk. Human Milk remains a vital source as it naturally contains beneficial oligosaccharides that contribute to infant health and development, promoting gut health and immunity. This naturally derived segment is particularly significant due to the increasing recognition of its nutritional advantages and the growing preference for breastfeeding. On the other hand, Synthetic Production is gaining traction as advancements in technology allow for the creation of oligosaccharides that mimic those found in human milk, providing a viable alternative for consumers seeking functional benefits without relying solely on human sources.Meanwhile, Animal Milk offers another avenue, appealing particularly to those who may not have direct access to human milk or prefer a dairy-based option. The diversity within this Source segment illustrates the potential for expansive growth and adaptation in catering to various consumer preferences and nutritional needs, as the US Human Milk Oligosaccharides Market continues to evolve amidst changing dietary patterns and health consciousness among families.
Human Milk Oligosaccharides Market Form Insights
The US Human Milk Oligosaccharides Market, particularly focusing on the Form segment, showcases significant diversity with its products categorized into various formats such as Powder, Liquid, and Capsules. This market has gained momentum due to the rising adoption of human milk oligosaccharides (HMOs) in infant nutrition and dietary supplements, emphasizing the growing consumer awareness regarding health benefits. The Powder form is recognized for its convenience and versatility, making it a prominent choice among parents for infant formula. Meanwhile, the Liquid format is perceived as user-friendly, appealing to consumers seeking immediate use and easy incorporation into feeding routines.Capsules, on the other hand, cater to adults looking to benefit from the prebiotic effects of HMOs, highlighting the expanding applications beyond infant nutrition. Trends indicate robust demand driven by health-conscious consumers and increased recognition of the functional benefits associated with HMOs, including improved gut health and immune support. Challenges remain in terms of regulatory hurdles and sourcing of high-quality ingredients, yet the opportunities for innovation and new product development in this thriving market segment remain substantial.Overall, the Form segment represents a crucial part of the overall US Human Milk Oligosaccharides Market, reflecting varied consumer preferences and enhancing market growth.
Human Milk Oligosaccharides Market End Use Insights
The US Human Milk Oligosaccharides Market has shown significant growth potential, particularly within the End Use segment, which encompasses various applications such as Healthcare, Food and Beverages, and Nutraceuticals. As awareness about the health benefits of Human Milk Oligosaccharides increases, the Healthcare sector plays a crucial role by incorporating these compounds into infant formulas and therapeutic products aimed at enhancing gut health and immune response. The Food and Beverages segment, meanwhile, is witnessing a rise in demand for functional foods enriched with Human Milk Oligosaccharides, aligning with consumer trends towards healthier eating habits and nutrition.Additionally, the Nutraceuticals sector is significant, with a growing focus on preventive healthcare and wellness products. This trend generates opportunities for innovation and product development, as brands look to leverage the unique properties of Human Milk Oligosaccharides for enhancing the nutritional profile of their offerings. As these segments evolve, they contribute to a broader understanding of the importance of Human Milk Oligosaccharides in supporting health and well-being, addressing consumer needs for clean labels and scientifically backed ingredients that promote better health outcomes.
US Human Milk Oligosaccharides Market Key Players and Competitive Insights
The US Human Milk Oligosaccharides Market is characterized by a growing demand for functional ingredients that enhance infant nutrition and promote health. This market is witnessing significant advancements driven by increased consumer awareness around the importance of gut health and immune function for infants. Companies are focusing on innovation and research to develop high-quality human milk oligosaccharides (HMOs) that are perceived as beneficial for both infants and their mothers. As this market continues to evolve, competitive insights reveal a landscape filled with both established players and emerging startups, all vying for a share in this lucrative field. The interplay between technological advancements and regulatory aspects will shape the strategies employed by these companies to effectively position themselves within the market.Ginkgo BioWorks has established a significant presence in the US Human Milk Oligosaccharides Market, leveraging its strengths in synthetic biology to develop innovative oligosaccharide products. The company utilizes advanced genetic engineering techniques, allowing for the creation of tailored human oligosaccharides that meet the growing needs of the infant nutrition segment. Ginkgo BioWorks has built strong partnerships and collaborations that enhance its research and development capabilities, subsequently leading to a robust pipeline of products aimed at addressing specific health benefits for infants. With a focus on quality and consistency, the company's strategic positioning and expertise in bioengineering enable it to cater to the rising demand for HMOs effectively.Tate and Lyle is a key player in the US Human Milk Oligosaccharides Market, recognized for its commitment to innovation and product development in the realm of nutritional ingredients. The company offers a range of key products that focus on enhancing infant nutrition, including various HMOs that provide health benefits such as improved gut health and immune support. Tate and Lyle's strong market presence is bolstered by its ongoing research and development initiatives, which ensure the alignment of its products with consumer preferences and regulatory standards. The company's strategic focus on mergers and acquisitions has strengthened its position in the US market, allowing for expanded capabilities in the nutritional space. This proactive approach to fostering innovation, coupled with an emphasis on sustainability, cements Tate and Lyle’s reputation as a leader in the human milk oligosaccharides sector, addressing the needs of both consumers and manufacturers across the country.
Key Companies in the US Human Milk Oligosaccharides Market Include
US Human Milk Oligosaccharides Market Industry Developments
Recent developments in the US Human Milk Oligosaccharides Market highlight significant growth and interest from major companies. Ginkgo BioWorks is focusing on biomanufacturing solutions to enhance the production of Human Milk Oligosaccharides, while Abbott Laboratories and Nestle continue to expand their product lines featuring these ingredients, aiming to cater to the growing demand for infant nutrition. In September 2023, Nielsen reported a substantial increase in demand for products containing Human Milk Oligosaccharides, indicating increasing consumer awareness about their benefits in infant formula. Notable mergers include Tate and Lyle's acquisition of a smaller firm to boost its capabilities in functional sweeteners, relevant to the Human Milk Oligosaccharides market. Furthermore, FrieslandCampina and Prolacta Bioscience have been collaborating on Research and Development initiatives to advance the applications of Human Milk Oligosaccharides in health products, aligning with a broader trend towards enhancing infant health. The market valuation of US-based companies has seen upward trends, attributed to rising investments and innovations in this sector, emphasizing the significance of R&D and strategic partnerships. In the last two years, increased consumer interest and regulatory support have further accelerated growth opportunities within this specialized market.
US Human Milk Oligosaccharides Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 114.75(USD Million) |
| MARKET SIZE 2024 | 130.5(USD Million) |
| MARKET SIZE 2035 | 562.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 14.204% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Ginkgo BioWorks, Tate and Lyle, PepsiCo, Abbott Laboratories, Nestle, GeneXus, Prolacta Bioscience, FrieslandCampina, Nutribén, Johnson and Johnson, Bifidobacterium, Danone, Synlogic, Finyou |
| SEGMENTS COVERED | Application, Source, Form, End Use |
| KEY MARKET OPPORTUNITIES | Growing infant formula demand, Increasing awareness of gut health, Rising R&D investments, Expanding dietary supplement market, Enhancing product fortification options |
| KEY MARKET DYNAMICS | rising demand for infant formulas, increasing awareness of health benefits, advancements in biotechnology, strong research and development activities, growing emphasis on gut health |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Human Milk Oligosaccharides Market is expected to be valued at 130.5 million USD in 2024.
By 2035, the US Human Milk Oligosaccharides Market is projected to be valued at 562.5 million USD.
The expected CAGR for the US Human Milk Oligosaccharides Market during the forecast period from 2025 to 2035 is 14.204%.
The Infant Formula segment is projected to reach a value of 225.0 million USD by 2035.
The Functional Foods segment is valued at 40.0 million USD in the year 2024.
The Dietary Supplements segment is expected to be valued at 167.5 million USD in 2035.
Major players include Ginkgo BioWorks, Tate and Lyle, PepsiCo, Abbott Laboratories, and Nestle.
The application segment of Infant Formula is expected to be a significant driver of growth in the market.
There is a notable trend toward increasing demand for infant nutrition products incorporating Human Milk Oligosaccharides.
The market could face challenges related to regulatory requirements and competition from alternative ingredients.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager - Research High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. by implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in packaging, construction, and equipment domains. she handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
